EMERGING LIQUISOLID COMPACT TECHNOLOGY FOR SOLUBILITY ENHANCEMENT OF DRUG ROSUVASTATIN BCS CLASS-II

Emerging Liquisolid Compact Technology for Solubility Enhancement of BCS Class-II Drug

Diazepam possesses potent anti-epileptic, anti-anxiety activity and also indicated for the treatment of insomnia. It is very slightly soluble in water and shows poor dissolution. Presently, liquisolid compact technique is found to be used extensively as one of the successful tool to enhance the solubility and dissolution of various poorly soluble drugs. The principle focus of this study is to f...

Dissolution Enhancement of Rosuvastatin Calcium by Liquisolid Compact Technique

In present investigation liquisolid compact technique is investigated as a tool for enhanced dissolution of poorly water-soluble drug Rosuvastatin calcium (RVT). The model drug RVT, a HMG-Co A reductase inhibitor was formulated in form of directly compressed tablets and liquisolid compacts; and studied for in-vitro release characteristics at different dissolution conditions. In this technique, ...

Solubility Enhancement of Carvedilol Using Liquisolid Compact Technique

A novel liquisolid compact technique was used for soulbility enahncement of poorly water soluble drug carvedilol (CAR). CAR was dissolved in water miscible non volatile solvent and then adsorbed on a solid carrier which was later compacted with other excipient into a tablet. The tablets were characterized with respect to hardness, friability, disintegration and in-vitro dissolution profile. Eff...

Application of liquisolid technology for enhancing solubility and dissolution of rosuvastatin.

PURPOSE Rosuvastatin is a poorly water soluble drug and the rate of its oral absorption is often controlled by the dissolution rate in the gastrointestinal tract. Hence it is necessary to increase the solubility of the Rosuvastatin. METHODS Several liquisolid tablets formulations containing various drug concentrations in liquid medication (ranging from 15% to 25% w/w) were prepared. The ratio...

Studies on Enhancement of Solubility and Bioavailability of Bcs Class Ii/iv Drugs